drugset / Trial / NCT01754818
A Phase 1 Study Examining the Pharmacokinetics and Tolerability of a Single Oral Dose of Bendavia (MTP-131)
RandomizedParallel-groupTriple-blindBasic science
Summary
The purpose of this study is to assess the study medication blood levels after administration of a single oral capsule of Bendavia at one of three dose levels. The effects of Bendavia on the volunteers will also be assessed.
Timeline
- Start
- 2012-11
- Primary completion
- 2013-01
- Completion
- 2013-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Elamipretide | Peptide | 10 mg | Oral |
| Subject | Elamipretide | Peptide | 50 mg | Oral |
| Subject | Elamipretide | Peptide | 100 mg | Oral |
Indications
No indication recorded.